Moxidectin for LF, Cote d'Ivoire (DOLF)

NCT04410406 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

164

Enrollment

OTHER

Sponsor class

Conditions

Lymphatic Filariasis

Interventions

DRUG: Ivermectin
DRUG: Diethylcarbamazine
DRUG: Albendazole
DRUG: Moxidectin

Sponsor

Washington University School of Medicine

Collaborators

[object Object]
[object Object]